Masaru Miyanaga

613 total citations
16 papers, 463 citations indexed

About

Masaru Miyanaga is a scholar working on Ophthalmology, Neurology and Epidemiology. According to data from OpenAlex, Masaru Miyanaga has authored 16 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Masaru Miyanaga's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Ocular Infections and Treatments (6 papers) and Retinal and Optic Conditions (4 papers). Masaru Miyanaga is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Ocular Infections and Treatments (6 papers) and Retinal and Optic Conditions (4 papers). Masaru Miyanaga collaborates with scholars based in Japan, United States and Switzerland. Masaru Miyanaga's co-authors include Manabu Mochizuki, Kazunori Miyata, Tatsushi Kawaguchi, Sunao Sugita, Hiroshi Takase, Ryohei Nejima, Norio Shimizu, Shigeru Kinoshita, Takashi Miyai and Tomohiro Morio and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, British Journal of Ophthalmology and Journal of Cataract & Refractive Surgery.

In The Last Decade

Masaru Miyanaga

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaru Miyanaga Japan 12 377 119 51 43 32 16 463
Norman Saffra United States 10 228 0.6× 49 0.4× 28 0.5× 35 0.8× 33 1.0× 47 384
Parthopratim Dutta Majumder India 8 216 0.6× 45 0.4× 31 0.6× 29 0.7× 9 0.3× 33 292
Marie‐Hélène Errera France 13 354 0.9× 87 0.7× 31 0.6× 38 0.9× 23 0.7× 47 480
Cristóbal Couto Argentina 11 366 1.0× 64 0.5× 93 1.8× 16 0.4× 7 0.2× 31 426
Ahmad B. Tarabishy United States 8 233 0.6× 45 0.4× 52 1.0× 45 1.0× 16 0.5× 15 384
Deena Tajfirouz United States 8 89 0.2× 67 0.6× 41 0.8× 75 1.7× 81 2.5× 26 235
G.S. Baarsma Netherlands 10 125 0.3× 88 0.7× 69 1.4× 17 0.4× 7 0.2× 16 299
Samendra Karkhur India 9 176 0.5× 25 0.2× 29 0.6× 30 0.7× 13 0.4× 33 259
Manisha Agarwal India 11 240 0.6× 24 0.2× 29 0.6× 22 0.5× 11 0.3× 36 329
M. Labetoulle France 9 212 0.6× 144 1.2× 7 0.1× 24 0.6× 16 0.5× 31 336

Countries citing papers authored by Masaru Miyanaga

Since Specialization
Citations

This map shows the geographic impact of Masaru Miyanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Miyanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Miyanaga more than expected).

Fields of papers citing papers by Masaru Miyanaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Miyanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Miyanaga. The network helps show where Masaru Miyanaga may publish in the future.

Co-authorship network of co-authors of Masaru Miyanaga

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Miyanaga. A scholar is included among the top collaborators of Masaru Miyanaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Miyanaga. Masaru Miyanaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miyanaga, Masaru, Hiroshi Takase, & Kyoko Ohno‐Matsui. (2020). Anti-Neutrophil Cytoplasmic Antibody-Associated Ocular Manifestations in Japan: A Review of 18 Patients. Ocular Immunology and Inflammation. 29(5). 991–996. 8 indexed citations
2.
Miyanaga, Masaru, Hiroshi Takase, Tatsushi Kawaguchi, et al.. (2015). [Clinical Survey of Uveitis in Tokyo Medical and Dental University--Comparison between the Periods of 1998-2001 and 2007-2011].. PubMed. 119(10). 678–85. 1 indexed citations
3.
Noguchi, Yoshihiro, Hiroshi Takase, Masaru Miyanaga, et al.. (2014). Audiovestibular findings in patients with Vogt-Koyanagi-Harada disease. Acta Oto-Laryngologica. 134(4). 339–344. 17 indexed citations
4.
Takase, Hiroshi, Yukiko Terada, Ayano Imai, et al.. (2014). Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Japanese Journal of Ophthalmology. 58(6). 473–482. 74 indexed citations
5.
Kawaguchi, Tatsushi, Koju Kamoi, Masaru Miyanaga, et al.. (2013). Clinical course of patients with Behçet’s uveitis following discontinuation of infliximab therapy. Japanese Journal of Ophthalmology. 58(1). 75–80. 13 indexed citations
6.
Takahashi, Hiroyuki, Hiroshi Takase, Masaru Miyanaga, et al.. (2013). CHOROIDAL THICKNESS IN CONVALESCENT VOGT–KOYANAGI–HARADA DISEASE. Retina. 34(4). 775–780. 45 indexed citations
7.
Kawaguchi, Tatsushi, Sunao Sugita, Yukiko Yamada, Masaru Miyanaga, & Manabu Mochizuki. (2010). Regression of Optic Disc Neovascularization in Patients with Behçet's Uveoretinitis After Infliximab Therapy. Journal of Ocular Pharmacology and Therapeutics. 26(6). 627–630. 10 indexed citations
8.
Miyanaga, Masaru, Tatsushi Kawaguchi, Kazunori Miyata, et al.. (2010). Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Japanese Journal of Ophthalmology. 54(5). 377–382. 42 indexed citations
9.
Miyanaga, Masaru, et al.. (2009). Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. Acta Ophthalmologica. 87(3). 300–305. 53 indexed citations
10.
Miyanaga, Masaru, Sunao Sugita, Norio Shimizu, et al.. (2009). A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. British Journal of Ophthalmology. 94(3). 336–340. 84 indexed citations
11.
Miyanaga, Masaru, Ryohei Nejima, Takashi Miyai, et al.. (2009). Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. Journal of Cataract & Refractive Surgery. 35(11). 1970–1978. 20 indexed citations
12.
Miyanaga, Masaru, Kentaro Shimizu, Tatsushi Kawaguchi, Kazunori Miyata, & Manabu Mochizuki. (2009). A Clinical Survey of Uveitis in HTLV-1 Endemic Region. Ocular Immunology and Inflammation. 17(5). 335–341. 28 indexed citations
13.
Aihara, Makoto, Masaru Miyanaga, Keiichiro Minami, et al.. (2008). A Comparison of Fluoroquinolone Penetration into Human Conjunctival Tissue. Journal of Ocular Pharmacology and Therapeutics. 24(6). 587–592. 11 indexed citations
14.
Miyanaga, Masaru, et al.. (2007). Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt–Koyanagi–Harada disease. International Ophthalmology. 27(2-3). 183–188. 20 indexed citations
15.
Wallace, Dana, Defen Shen, George F. Reed, et al.. (2006). Detection of thebcl-2t(14;18) Translocation and Proto-Oncogene Expression in Primary Intraocular Lymphoma. Investigative Ophthalmology & Visual Science. 47(7). 2750–2750. 36 indexed citations
16.
Miyanaga, Masaru, Motohiro Kiyosawa, Hiroshi Takase, et al.. (2004). Microdissection and Gene Rearrangement Analysis of Paraffin-embedded Specimens of Orbital Malignant Lymphoma. Japanese Journal of Ophthalmology. 48(2). 123–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026